Fibrogenic Gene Signature as Early Prediction for the Efficacy of Pharmacological Interventions for <scp>MASH</scp> ‐Associated Fibrosis
José A. Inia(Netherlands Organisation for Applied Scientific Research), Anita M. van den Hoek(Netherlands Organisation for Applied Scientific Research)
Cited by 2
Related Papers
A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology
|Cells|2020|42
Beneficial effects of elafibranor on NASH in E3L.CETP mice and differences between mice and men
|Scientific Reports|2021|22
Translatability of mouse muscle-aging for humans: the role of sex
|GeroScience|2024|16
Atorvastatin Attenuates Diet-Induced Non-Alcoholic Steatohepatitis in APOE*3-Leiden Mice by Reducing Hepatic Inflammation
|International Journal of Molecular Sciences|2023|15